Lupin (NSE:LUPIN) Beginning Cash Position : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Beginning Cash Position?

Lupin's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Lupin's annual Beginning Cash Position increased from Mar. 2022 (₹9,262 Mil) to Mar. 2023 (₹9,914 Mil) and increased from Mar. 2023 (₹9,914 Mil) to Mar. 2024 (₹12,318 Mil).

Lupin Beginning Cash Position Historical Data

The historical data trend for Lupin's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Beginning Cash Position Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Beginning Cash Position

Get a 7-Day Free Trial

5,440.60

22,293.10

9,262.20

9,913.70

12,318.10

Lupin Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Lupin Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Lupin Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Lupin's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Beginning Cash Position

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines